MOSQUIRIX VACCINE

Indications

• Acute uncomplicated malaria
• Severe malaria
• Chemoprophylaxis in travelers
• Relapse prevention in individuals with a history of malaria

Dosage

Children: Refer to specific paediatric dosing guidelines for antimalarial medications, as these depend on the specific drug and the child's weight and age.

Adults: Refer to specific antimalarial dosing guidelines based on the drug used, as doses vary significantly among different agents.

Mechanism of action

Plasmodium falciparum invades red blood cells and utilizes hemoglobin for its nutrition. It produces toxic metabolites such as hemozoin, which contribute to the pathogenesis of malaria. Antimalarial drugs, such as artemisinin and chloroquine, target various stages of the parasite's life cycle, disrupting its ability to metabolize hemoglobin and reproduce.

Pharmacodynamics

Antimalarial drugs have different mechanisms of action based on their class. For instance, artemisinin derivatives produce reactive oxygen species that damage the parasite. Quinine and its derivatives inhibit heme polymerization, leading to the accumulation of toxic heme in the parasite. The efficacy of these drugs depends on the stage of the parasite in the lifecycle, with some being more effective against blood stages while others target gametocytes.

Pharmacokinetics

The pharmacokinetics of antimalarial agents can vary widely. Most are rapidly absorbed after oral administration, with peak plasma concentrations occurring within hours. They are metabolized primarily in the liver, and their half-lives can range from hours to days, impacting dosing frequency. Most antimalarials are excreted through urine, and dosing may need adjustment in cases of renal impairment.

Adverse effects

• Nausea
• Vomiting
• Diarrhea
• Headache
• Dizziness
• Rash
• Hypersensitivity reactions

Interactions

• May interact with anticoagulants, leading to increased bleeding risk
• Concomitant use with other antimalarials may alter efficacy
• Potential interaction with medications that affect liver enzymes

Precautions

• Use with caution in patients with liver impairment
• Monitor for signs of hemolysis in patients with G6PD deficiency
• Assess for potential drug interactions before prescribing

Pregnancy

Use is generally not recommended unless the potential benefit justifies the risk to the fetus. Consult local guidelines.

Breast-feeding

May be excreted in breast milk; caution is advised when administering to nursing mothers.

Storage

Store in a cool, dry place away from light. Keep out of reach of children.

Formulations

• Tablets
• Injectable solutions
• Oral suspensions

Indications

• Acute viral hepatitis
• Chronic hepatitis B
• Chronic hepatitis C
• Autoimmune hepatitis
• Alcoholic hepatitis
• Non-alcoholic fatty liver disease

Dosage

Children: Paediatric dosing also varies significantly based on the specific condition and medication. As with adult dosing, it is important to refer to the BNF for Children for specific recommendations.

Adults: Dosing for adult patients varies widely depending on the specific antiviral agent used and the type of hepatitis. It is essential to refer to specific guidelines or the BNF for precise dosing.

Mechanism of action

In viral hepatitis, the viruses typically enter liver cells and replicate, leading to cellular injury and inflammation. The immune response to the infection contributes to liver damage. Antiviral therapies aim to inhibit viral replication, either by directly targeting viral enzymes or by modulating the host immune response.

Pharmacodynamics

The pharmacodynamics of antiviral agents used in hepatitis treatment involve the inhibition of viral replication, reduction of viral load, and improvement of liver function. This can lead to a decrease in serum liver enzymes (ALT and AST) and an improvement in clinical symptoms. In chronic hepatitis B and C, sustained virologic response is the goal, indicating effective viral suppression.

Pharmacokinetics

The pharmacokinetics of antiviral medications used for hepatitis can vary significantly depending on the specific drug. Generally, these agents are absorbed from the gastrointestinal tract, metabolized in the liver, and excreted through urine or feces. The half-lives of these drugs can vary, influencing dosing schedules.

Pregnancy

Consult medical guidelines as hepatitis can pose risks during pregnancy; specific management depends on the type of hepatitis.

Breast-feeding

Consult healthcare providers, as the safety of certain hepatitis medications during breastfeeding varies.

Storage

Store in a cool, dry place away from direct sunlight; specific storage conditions may vary based on the medication used.

Indications

• Malaria caused by Plasmodium falciparum
• Malaria caused by Plasmodium vivax
• Relapse prevention in Plasmodium vivax malaria
• Severe malaria requiring parenteral therapy

Dosage

Adults: Dosage for adult antimalarial treatments varies by specific medication and severity of infection. Please refer to specific guidelines and BNF resources for accurate dosing information.

Mechanism of action

Plasmodium parasites invade red blood cells, where they metabolize hemoglobin and reproduce. The parasites undergo a complex life cycle involving liver and blood stages, leading to symptoms such as fever, chills, and anemia. Antimalarial drugs target various stages of this life cycle, disrupting the parasite's metabolism and replication processes.

Pharmacodynamics

The pharmacodynamics of antimalarial treatments vary depending on the specific medication used. For example, artemisinin-based therapies act quickly to reduce the parasite load in the blood, while other drugs like chloroquine and quinine inhibit heme polymerization, leading to toxic accumulation of heme in the parasite. The effectiveness of treatment is influenced by factors such as drug resistance, the species of Plasmodium, and the severity of the infection.

Pharmacokinetics

The pharmacokinetics of antimalarial drugs vary widely. For instance, artemisinin is rapidly absorbed and has a short half-life, necessitating combination with longer-acting drugs to ensure efficacy. Chloroquine has a longer half-life and is well-absorbed from the gastrointestinal tract, accumulating in tissues. The distribution, metabolism, and excretion of these drugs can be affected by individual patient factors, including age, weight, and the presence of co-morbidities.

Adverse effects

• Nausea
• Vomiting
• Diarrhea
• Headache
• Dizziness
• Fatigue
• Anemia
• Hypersensitivity reactions

Precautions

• Monitor for signs of resistance in endemic areas
• Assess for potential drug interactions
• Use caution in patients with liver impairment
• Consider monitoring blood glucose levels in patients with diabetes

Pregnancy

Consult with a healthcare provider. Some antimalarial treatments may not be safe during pregnancy.

Breast-feeding

Generally, many antimalarial medications are considered acceptable during breastfeeding, but specific guidance should be sought.

Storage

Store in a cool, dry place away from light. Check specific storage conditions for formulations.

Indications

• Prevention of infectious diseases such as measles, mumps, rubella, hepatitis B, influenza, and human papillomavirus (HPV)
• Travel vaccinations for diseases endemic to certain regions
• Vaccination for at-risk populations, such as those with compromised immune systems or specific occupational exposures

Dosage

Children: Dosage varies by vaccine type and age; refer to the BNF for Children for specific dosing information.

Adults: Dosage varies by vaccine type and indication; refer to specific guidelines for each vaccine.

Mechanism of action

Vaccines work by mimicking an infection. They introduce a harmless component of a pathogen (antigen) to the immune system, prompting the body to produce an immune response. This includes the generation of antibodies and memory cells that provide long-term immunity. Upon subsequent exposure to the actual pathogen, the immune system is primed to respond more rapidly and effectively.

Pharmacodynamics

The pharmacodynamics of vaccines involves the activation of both humoral and cellular immunity. Vaccines stimulate B cells to produce antibodies against the pathogen, while T cells are activated to destroy infected cells. This dual response helps to establish immunological memory, which enables a faster and more robust response upon re-exposure to the pathogen.

Pharmacokinetics

Vaccines are administered via various routes, including intramuscular, subcutaneous, and oral. After administration, the antigens are presented to antigen-presenting cells, which activate T cells and stimulate B cell proliferation and differentiation. The half-life of vaccine-induced immunity varies depending on the type of vaccine, with some providing lifelong immunity and others requiring booster doses to maintain protection.

Contra-indications

• Severe allergic reaction (anaphylaxis) to a component of the vaccine
• Severe immunocompromised state for live attenuated vaccines

Adverse effects

• Local reactions at the injection site (pain, redness, swelling)
• Fever
• Fatigue
• Headache
• Muscle pain
• Joint pain
• Nausea

Interactions

• Immunosuppressive medications may reduce vaccine efficacy
• Concurrent administration of some vaccines may require spacing to optimize immune response

Precautions

• History of allergic reactions to vaccines or vaccine components
• Pregnancy (specific vaccines may be contraindicated)
• Moderate to severe acute illness with or without fever

Pregnancy

Consult healthcare provider. Some vaccines are contraindicated during pregnancy, while others are recommended.

Breast-feeding

Generally considered safe, but consult healthcare provider regarding specific vaccines.

Storage

Store in a refrigerator at 2-8°C. Do not freeze. Protect from light.

Formulations

• Liquid suspension for injection
• Lyophilized powder for reconstitution